GL
Geulah Livshits Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
90
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $74 |
28%
upside
| 1 | +5% |
0
%
| 26 Nov ‘25 8 days ago |
|
|
|
Buy
Maintained
| $25 |
122%
upside
| 1 | +9.1% |
0
%
| 24 Nov ‘25 10 days ago |
|
|
|
Buy
Maintained
| $110 |
18%
upside
| 3 | +41% |
0
%
| 13 Nov ‘25 21 days ago |
|
|
|
Buy
Maintained
| $20 |
199%
upside
| 2 | +29% |
0
%
| 13 Nov ‘25 21 days ago |
|
|
|
Buy
Maintained
| $21 |
148%
upside
| 1 | -1.4% |
0
%
| 12 Nov ‘25 22 days ago |
|
|
|
Buy
Maintained
| $26 |
131%
upside
| 1 | +16% |
0
%
| 11 Nov ‘25 23 days ago |
|
|
|
Buy
Maintained
| $9 |
538%
upside
| 1 | +14% |
0
%
| 10 Nov ‘25 24 days ago |
|
|
|
Buy
Maintained
| $9 |
125%
upside
| 1 | +20% |
0
%
| 10 Nov ‘25 24 days ago |
|
|
|
Buy
Maintained
| $26 |
168%
upside
| 2 | +14% |
0
%
| 7 Nov ‘25 26 days ago |
|
|
|
Buy
Maintained
| $17 |
662%
upside
| 1 | -10% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Buy
Maintained
| $17 |
88%
upside
| 2 | +24% |
0
%
| 5 Nov ‘25 28 days ago |
|
|
|
Buy
Maintained
| $12 |
141%
upside
| 2 | +28% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Buy
Maintained
| $15 |
164%
upside
| 1 | +16% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $220 |
0%
upside
| 1 | +3.2% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $11 |
220%
upside
| 1 | -5.7% |
0
%
| 14 Oct ‘25 1 month ago |
|